Alife Health partners with US fertility to pilot embryology laboratory AI tools

Alife Health, a technology company building AI tools to advance in-vitro fertilisation (IVF) in the US, is partnering with US Fertility to pilot Alife’s Embryo Assist software to enrich embryo cataloguing.

Alife’s Embryo Assist integrates with laboratory microscopes, enabling embryologists to easily capture embryo images and data to elevate laboratory quality-control measures.

The tool generates comprehensive activity and audit trails for each embryo, while its cloud-based platform provides real-time lab updates, ensuring embryologists have immediate access to the latest data for informed decision-making.

“Our partnership with Alife marks a significant advancement in our laboratory capabilities,” said Kate Devine, MD, Medical Director and Chief Research Officer of US Fertility.

“By integrating AI and data-driven tools into our IVF processes, we aim to continue delivering exceptional care to our patients while providing them with further insight into the precision and consistency of our laboratories.”

“Alife is honoured to partner with US Fertility to bring our cutting-edge AI solutions into their laboratories,” said Melissa Teran, CEO of Alife Health.

“Through this pilot collaboration, we will equip embryologists with a powerful tool that streamlines operations and enhances clinical efficiency.”